Inretio

Ischemic Stroke Treatment

Health Tech & Life Sciences
Private
Follow

Company Overview

Snapshot

Founded in December 2017 by Raviv Vine, Inretio operates with 1–10 employees. The company has raised $2.5M across one funding round. In February 2023, Inretio received A Round funding from Therma Bright.

Business overview

Inretio is a Health Tech & Life Sciences company focused on developing solutions for ischemic stroke treatment. The company's core technology addresses complications that arise during clot retrieval procedures, aiming to improve outcomes for patients. Inretio operates within the medical devices sector, specifically targeting medical treatment and therapeutics, and serves healthcare providers.

Log in to access full profile

Company Intelligence Q&A

When was Inretio founded?
Inretio was founded in December 2017.
Who is the founder of Inretio?
Raviv Vine is the founder of Inretio.
What is Inretio's primary sector?
Inretio's primary sector is Health Tech & Life Sciences.
How much capital has Inretio raised?
Inretio has raised a total of $2.5M.
Log in to access full profile